Journal Home
Search for

Volume 50, Issue 2, Pages 353-357 (1 June 2001)


View previous. 9 of 36 View next.

Acupuncture for pilocarpine-resistant xerostomia following radiotherapy for head and neck malignancies1

Presented in part at ESTRO-MITRE meeting, Brussels, Belgium, December 2000.

Peter A.S Johnstone, M.D. (M.A.)Corresponding Author Informationemail address, Y.Peter Peng, M.D., Byron C May, M.D., Warren S Inouye, M.D., Richard C Niemtzow, M.D., Ph.D. (M.P.H.)

Accepted 20 October 2000.

Abstract 

Objective: Xerostomia is a frequent and potentially debilitating toxicity of radiotherapy (XRT) for cancers of the head and neck. This report describes the use of acupuncture as palliation for such patients.

Methods and Materials: Eighteen patients with xerostomia refractory to pilocarpine therapy after XRT for head and neck malignancy were offered acupuncture as palliation. All patients are without evidence of cancer recurrence at the primary site. Acupuncture was provided to three auricular points and one digital point bilaterally, with electrostimulation used variably. The Xerostomia Inventory (XI) was administered retrospectively to provide an objective measure of efficacy.

Results: Acupuncture contributed to relief from xerostomia to varying degrees. Palliative effect as measured by the XI varied from nil to robust (pre- minus post- therapy values of over 20 points). Nine patients had benefit of over 10 points on the XI.

Conclusions: Acupuncture reduces xerostomia in some patients who are otherwise refractory to best current management.

 Radiation Oncology Division, Naval Medical Center, San Diego, CA USA

 Radiation Oncology Division, University of California, San Diego, CA USA

Corresponding Author InformationReprint requests to: CDR Peter A. S. Johnstone, MC, USN, Naval Medical Center of San Diego, Radiation Oncology Division, 34800 Bob Wilson Drive, Suite 14, San Diego, CA 92134-1014. Tel: (619) 532-7274; Fax: (619) 532-8178

1 The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the United States Government.

PII: S0360-3016(00)01530-3


View previous. 9 of 36 View next.